OBJECTIVE: In humans, evidence about the association between levels of monocyte chemoattractant protein-1 (MCP-1), its coding gene chemokine (C-C motif) ligand 2 (CCL2), and risk of coronary artery disease (CAD) is contradictory. METHODS AND RESULTS: We performed a nested case-control study in the prospective EPIC-Norfolk cohort investigating the relationship between CCL2 single-nucleotide polymorphisms (SNPs), MCP-1 concentrations, and the risk of future CAD. Cases (n=1138) were apparently healthy men and women aged 45 to 79 years who developed fatal or nonfatal CAD during a mean follow-up of 6 years. Controls (n=2237) were matched by age, sex, and enrollment time. Using linear regression analysis no association between CCL2 SNPs and MCP-1 serum concentrations became apparent, nor did we find a significant association between MCP-1 serum levels and risk of future CAD. Finally, Cox regression analysis showed no significant association between CCL2 SNPs and the future CAD risk. In addition, we did not find any robust associations between the CCL2 haplotypes and MCP-1 serum concentration or future CAD risk. CONCLUSIONS: Our data do not support previous publications indicating that MCP-1 is involved in the pathogenesis of CAD.
OBJECTIVE: In humans, evidence about the association between levels of monocyte chemoattractant protein-1 (MCP-1), its coding gene chemokine (C-C motif) ligand 2 (CCL2), and risk of coronary artery disease (CAD) is contradictory. METHODS AND RESULTS: We performed a nested case-control study in the prospective EPIC-Norfolk cohort investigating the relationship between CCL2 single-nucleotide polymorphisms (SNPs), MCP-1 concentrations, and the risk of future CAD. Cases (n=1138) were apparently healthy men and women aged 45 to 79 years who developed fatal or nonfatal CAD during a mean follow-up of 6 years. Controls (n=2237) were matched by age, sex, and enrollment time. Using linear regression analysis no association between CCL2 SNPs and MCP-1 serum concentrations became apparent, nor did we find a significant association between MCP-1 serum levels and risk of future CAD. Finally, Cox regression analysis showed no significant association between CCL2 SNPs and the future CAD risk. In addition, we did not find any robust associations between the CCL2 haplotypes and MCP-1 serum concentration or future CAD risk. CONCLUSIONS: Our data do not support previous publications indicating that MCP-1 is involved in the pathogenesis of CAD.
Authors: M W T Tanck; A H E M Klerkx; J W Jukema; P De Knijff; J J P Kastelein; A H Zwinderman Journal: Ann Hum Genet Date: 2003-03 Impact factor: 1.670
Authors: Kevin Bacon; Marco Baggiolini; Hal Broxmeyer; Richard Horuk; Ivan Lindley; Alberto Mantovani; Kouji Maysushima; Philip Murphy; Hisayuki Nomiyama; Joost Oppenheim; Antal Rot; Thomas Schall; Monica Tsang; Robin Thorpe; Jo Van Damme; Meenu Wadhwa; Osamu Yoshie; Albert Zlotnik; Kathy Zoon Journal: J Interferon Cytokine Res Date: 2002-10 Impact factor: 2.607
Authors: F Cipollone; M Marini; M Fazia; B Pini; A Iezzi; M Reale; L Paloscia; G Materazzo; E D'Annunzio; P Conti; F Chiarelli; F Cuccurullo; A Mezzetti Journal: Arterioscler Thromb Vasc Biol Date: 2001-03 Impact factor: 8.311
Authors: Enrique Gonzalez; Brad H Rovin; Luisa Sen; Glen Cooke; Rahul Dhanda; Srinivas Mummidi; Hemant Kulkarni; Michael J Bamshad; Vanessa Telles; Stephanie A Anderson; Elizabeth A Walter; Kevin T Stephan; Michael Deucher; Andrea Mangano; Rosa Bologna; Seema S Ahuja; Matthew J Dolan; Sunil K Ahuja Journal: Proc Natl Acad Sci U S A Date: 2002-10-08 Impact factor: 11.205
Authors: Jan R Ortlepp; Katharina Vesper; Vera Mevissen; Fabian Schmitz; Uwe Janssens; Andreas Franke; Peter Hanrath; Christian Weber; Klaus Zerres; Rainer Hoffmann Journal: J Mol Med (Berl) Date: 2003-04-29 Impact factor: 4.599
Authors: James A de Lemos; David A Morrow; Marc S Sabatine; Sabina A Murphy; C Michael Gibson; Elliott M Antman; Carolyn H McCabe; Christopher P Cannon; Eugene Braunwald Journal: Circulation Date: 2003-02-11 Impact factor: 29.690
Authors: Julian Little; Julian P T Higgins; John P A Ioannidis; David Moher; France Gagnon; Erik von Elm; Muin J Khoury; Barbara Cohen; George Davey-Smith; Jeremy Grimshaw; Paul Scheet; Marta Gwinn; Robin E Williamson; Guang Yong Zou; Kim Hutchings; Candice Y Johnson; Valerie Tait; Miriam Wiens; Jean Golding; Cornelia van Duijn; John McLaughlin; Andrew Paterson; George Wells; Isabel Fortier; Matthew Freedman; Maja Zecevic; Richard King; Claire Infante-Rivard; Alex Stewart; Nick Birkett Journal: Genet Epidemiol Date: 2009-11 Impact factor: 2.135
Authors: F Canouï-Poitrine; G Luc; Z Mallat; E Machez; A Bingham; J Ferrieres; J-B Ruidavets; M Montaye; J Yarnell; B Haas; D Arveiler; P Morange; F Kee; A Evans; P Amouyel; P Ducimetiere; J-P Empana Journal: Neurology Date: 2011-08-17 Impact factor: 9.910
Authors: Marios K Georgakis; Rainer Malik; Harry Björkbacka; Tiberiu Alexandru Pana; Serkalem Demissie; Colby Ayers; Mohamed A Elhadad; Myriam Fornage; Alexa S Beiser; Emelia J Benjamin; S Matthijs Boekholdt; Gunnar Engström; Christian Herder; Ron C Hoogeveen; Wolfgang Koenig; Olle Melander; Marju Orho-Melander; Alexandru Schiopu; Martin Söderholm; Nick Wareham; Christie M Ballantyne; Annette Peters; Sudha Seshadri; Phyo K Myint; Jan Nilsson; James A de Lemos; Martin Dichgans Journal: Circ Res Date: 2019-09-03 Impact factor: 17.367
Authors: Minh-Hieu T Pham; Gregory B Bonello; John Castiblanco; Tuan Le; Jose Sigala; Weijing He; Srinivas Mummidi Journal: PLoS One Date: 2012-11-16 Impact factor: 3.240